We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Inspections Look Hard at Reporting Structure, Quality Staff, Former Investigator Says
FDA Inspections Look Hard at Reporting Structure, Quality Staff, Former Investigator Says
With the quality metrics movement resurfacing and CDER’s quality maturity model publication in the news, lately I have been giving much thought to what quality culture means and how to recognize a strong culture of quality in a pharmaceutical facility.